Carbapenems are first-line agents for the treatment of serious nosocomial infections caused by multidrug-resistant Enterobacteriaceae. However, resistance to carbapenems has increased dramatically among Enterobacteriaceae in our hospital. In this study, we report clonal dissemination caused by carbapenem-resistant Enterobacter aerogenes (CREA). In 2011, CREA was identified from 12 patients admitted to the neurosurgical ward. All 12 clinical isolates were non-susceptible to cefotaxime, ceftazidime, cefoxitin, ertapenem, imipenem or meropenem. All isolates carried the gene encoding Klebsiella pneumoniae carbapenemase-2 (KPC-2), except for the isolate E4. However, a remarkably lower expression level of the porin OmpF was detected in the non-KPC-2-producing isolate E4 on SDS-PAGE compared with the carbapenem-susceptible isolate. Epidemiological and molecular investigations showed that a single E. aerogenes strain (PFGE type A), including seven KPC-2-producing clinical isolates, was primarily responsible for the first isolation and subsequent dissemination. In a case-control study, we identified risk factors for infection/colonization with CREA. Mechanical ventilation, the changing of sickbeds and previous use of broad-spectrum antibiotics were identified as potential risk factors. Our findings suggest that further studies should focus on judicious use of available antibiotics, implementation of active antibiotic resistance surveillance and strict implementation of infection-control measures to avoid the rapid spread or clonal dissemination caused by carbapenem-resistant Enterobacteriaceae in healthcare facilities.
CantónR., AkóvaM., CarmeliY., GiskeC. G., GlupczynskiY., GniadkowskiM., LivermoreD. M., MiriagouV., NaasT.& other authors (2012; Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413–431 [View Article][PubMed]
ChenS., HuF., LiuY., ZhuD., WangH., ZhangY.2011b; Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China. Am J Infect Control 39:e55–e60 [View Article][PubMed]
ChenS., HuF., XuX., LiuY., WuW., ZhuD., WangH.2011c; High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum β-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China. Antimicrob Agents Chemother 55:2493–2494 [View Article][PubMed]
FalagasM. E., KarageorgopoulosD. E.2008; Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 46:1121–1122, author reply 1122 [View Article][PubMed]
FalagasM. E., KarageorgopoulosD. E., NordmannP.2011; Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol 6:653–666 [View Article][PubMed]
Fernández-CuencaF., Rodríguez-MartínezJ. M., Martínez-MartínezL., PascualA.2006; In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC β-lactamase. Int J Antimicrob Agents 27:549–552 [View Article][PubMed]
GayetS., CholletR., MolleG., PagèsJ. M., ChevalierJ.2003; Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob Agents Chemother 47:1555–1559 [View Article][PubMed]
HirschE. B., TamV. H.2010; Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 65:1119–1125 [View Article][PubMed]
LledoW., HernandezM., LopezE., MolinariO. L., SotoR. Q., HernandezE., SantiagoN., FloresM., VazquezG. J.Centers for Disease Control and Prevention (CDC)2009; Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 58:256–260[PubMed]
MurrayP. R., BaronE. J., JorgensenJ. H., LandryM. L., PfallerM. A.2007; Detection and characterization of antimicrobial resistance genes in pathogenic bacteria. In Manual of Clinical Microbiology, 9th edn. pp. 1250–1256 Edited by RasheedJ. K., CockerillF., TenoverF. C. Washington, DC: American Society for Microbiology;
PetrosilloN., GiannellaM., LewisR., VialeP.2013; Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther 11:159–177 [View Article][PubMed]
PfeiferY., CullikA., WitteW.2010; Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 300:371–379 [View Article][PubMed]
SzabóD., SilveiraF., HujerA. M., BonomoR. A., HujerK. M., MarshJ. W., BethelC. R., DoiY., DeeleyK., PatersonD. L.2006; Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob Agents Chemother 50:2833–2835 [View Article][PubMed]
TenoverF. C., ArbeitR. D., GoeringR. V., MickelsenP. A., MurrayB. E., PersingD. H., SwaminathanB.1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239[PubMed]
ThiolasA., BornetC., Davin-RégliA., PagèsJ. M., BolletC.2004; Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem Biophys Res Commun 317:851–856 [View Article][PubMed]
VardakasK. Z., TansarliG. S., RafailidisP. I., FalagasM. E.2012; Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother 67:2793–2803 [View Article][PubMed]
YangK., GuglielmoB. J.2007; Diagnosis and treatment of extended-spectrum and AmpC β-lactamase-producing organisms. Ann Pharmacother 41:1427–1435 [View Article][PubMed]
ZhangR., WangX. D., CaiJ. C., ZhouH. W., LvH. X., HuQ. F., ChenG. X.2011; Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital. J Med Microbiol 60:977–982 [View Article][PubMed]